Extreme genetic divergence is required for coreceptor switching in HIV-1 subtype C.
about
HIV-1 induced bystander apoptosisLongitudinal Analysis of CCR5 and CXCR4 Usage in a Cohort of Antiretroviral Therapy-Naïve Subjects with Progressive HIV-1 Subtype C Infection.Alterations in HIV-1 gp120 V3 region are necessary but not sufficient for coreceptor switching in CRF07_BC in China.Covariance of charged amino acids at positions 322 and 440 of HIV-1 Env contributes to coreceptor specificity of subtype B viruses, and can be used to improve the performance of V3 sequence-based coreceptor usage prediction algorithms.HIV-1 pathogenesis: the virus.CoRSeqV3-C: a novel HIV-1 subtype C specific V3 sequence based coreceptor usage prediction algorithmUtilization of HIV-1 envelope V3 to identify X4- and R5-specific Tat and LTR sequence signaturesMechanisms of HIV-1 subtype C resistance to GRFT, CV-N and SVN.Linkages between HIV-1 specificity for CCR5 or CXCR4 and in vitro usage of alternative coreceptors during progressive HIV-1 subtype C infection.Frequency and Env determinants of HIV-1 subtype C strains from antiretroviral therapy-naive subjects that display incomplete inhibition by maraviroc.Evolution of HIV-1 coreceptor usage and coreceptor switching during pregnancy.Escape from human immunodeficiency virus type 1 (HIV-1) entry inhibitors.Effect of HIV-1 subtype and tropism on treatment with chemokine coreceptor entry inhibitors; overview of viral entry inhibition.Human immunodeficiency virus type 1 biological variation and coreceptor use: from concept to clinical significance.Effect of Amino Acid Substitutions Within the V3 Region of HIV-1 CRF01_AE on Interaction with CCR5-Coreceptor.High-Sequence Diversity and Rapid Virus Turnover Contribute to Higher Rates of Coreceptor Switching in Treatment-Experienced Subjects with HIV-1 Viremia.
P2860
Q22241221-7E8E0AA5-A0A6-44E4-97C7-59D7FDDBF0FCQ34792976-AE471DF1-5900-49A7-B411-798F666568F3Q35133895-00BDA8E8-7D66-441B-999B-52429A195E60Q35330357-DD61CEEB-FC4A-4571-B726-E82A876D1262Q36526530-30BDC696-9636-4ACA-8B6A-D1F27264EF4BQ36690585-FEDE40FE-820A-4A5A-8EE0-4B54C18E1F52Q36867198-5A40D0D6-2DF8-4E3B-9CE4-5EB82EDF5BEDQ37208595-05042F29-98FA-45BE-963D-2570F308CE84Q37362368-C9E339AF-3EE3-462A-8E6A-BEBEF03EE5FAQ37390786-75C810E6-BF01-466E-8D1E-861556938B8CQ37610660-A42F3C96-86AA-4D5F-A6D4-F247B9906F6CQ38076139-7D252FE2-E3FA-41DF-AA21-CA753E223DBCQ38196457-D950F01E-FF54-4350-A374-46C6AFB6B326Q39471859-7D87E5C9-A260-45D0-A196-F8349780A165Q40204210-405BC817-4BAC-45DD-9697-971FE99ECA39Q40548483-345F8F1A-B38B-4E24-A8F4-09C2B92EBC6E
P2860
Extreme genetic divergence is required for coreceptor switching in HIV-1 subtype C.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Extreme genetic divergence is required for coreceptor switching in HIV-1 subtype C.
@ast
Extreme genetic divergence is required for coreceptor switching in HIV-1 subtype C.
@en
Extreme genetic divergence is required for coreceptor switching in HIV-1 subtype C.
@nl
type
label
Extreme genetic divergence is required for coreceptor switching in HIV-1 subtype C.
@ast
Extreme genetic divergence is required for coreceptor switching in HIV-1 subtype C.
@en
Extreme genetic divergence is required for coreceptor switching in HIV-1 subtype C.
@nl
prefLabel
Extreme genetic divergence is required for coreceptor switching in HIV-1 subtype C.
@ast
Extreme genetic divergence is required for coreceptor switching in HIV-1 subtype C.
@en
Extreme genetic divergence is required for coreceptor switching in HIV-1 subtype C.
@nl
P2093
P2860
P1476
Extreme genetic divergence is required for coreceptor switching in HIV-1 subtype C.
@en
P2093
Donald E Mosier
Mia Coetzer
Rebecca Nedellec
Tammy Meyers
Tonie Cilliers
P2860
P356
10.1097/QAI.0B013E3181F63906
P407
P50
P577
2011-01-01T00:00:00Z